arrow
A

Anwar Mohammad

Dasman Diabetes Institute
H指数:23
被引数:3,711

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Expression Profiling and Structure-Based Drug Discovery Identify EGFR as a Druggable Target and Tripterygium wilfordii Phytochemicals as Potential Therapeutics for Autosomal Dominant Polycystic Kidney Disease

整合表达谱分析与结构导向药物发现,将EGFR鉴定为可成药靶点,并将雷公藤(Tripterygium wilfordii)植物化学物鉴定为常染色体显性多囊肾病的潜在治疗药物

2026-10-060
PRE
ERβ-Score: An Interpretable Machine Learning-Based Scoring Function and Web Server for Estrogen Receptor β-Guided Drug Discovery in Triple-Negative Breast Cancer

ERβ评分:用于三阴性乳腺癌雌激素受体β指导药物发现的可解释机器学习评分函数及网络服务器

2026-08-140
OA
Combining Triazole Scaffold Repurposing and Generative Transformer Architecture for Structure-Based Inhibitor Design Targeting the LasR Quorum Sensing Receptor of Pseudomonas aeruginosa

结合三唑骨架重定位和生成式转换器架构,用于针对铜绿假单胞菌LasR群体感应受体的基于结构的抑制剂设计

2026-08-120
OA
An Integrative Computational Pipeline for CK2 Inhibitor Discovery in Triple−Negative Breast Cancer Using Virtual Screening, Molecular Dynamics, Machine Learning, and Density Functional Theory

利用虚拟筛选、分子动力学、机器学习和密度泛函理论整合计算流程,在 triple-negative breast cancer 中发现 CK2 抑制剂

2026-04-280
OAAI
Unraveling Verapamil's Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models
CELLS
IF5.2
2024-05-300
OAAI